Hypothalamic heat-regulating centre (POA)

The hypothalamic heat-regulating centre, primarily located in the preoptic area (POA) of the hypothalamus, serves as the central thermostat for maintaining core body temperature homeostasis (StatPearls, 2023; Siemens & Kamm, 2018). This functional region integrates thermal information from peripheral receptors in the skin and central thermosensitive neurons to coordinate physiological responses such as shivering, sweating, and vasomotor changes via the autonomic nervous system (NIH, 2024). During a febrile response, endogenous pyrogens like interleukin-1 stimulate the synthesis of prostaglandin E2 (PGE2), which acts on EP3 receptors within this centre to elevate the thermoregulatory set-point (Clinical Infectious Diseases, 1996; PNAS, 2010). Clinically significant drugs such as acetaminophen and non-steroidal anti-inflammatory drugs (NSAIDs) target this pathway by inhibiting cyclooxygenase (COX) enzymes, thereby reducing PGE2 levels and resetting the thermostat to its normal level (PubMed, 2014; News-Medical, 2022). Furthermore, emerging pharmaceutical research targets specific molecular receptors within this center, such as neurotensin receptor 1 (NTR1) and ion channels like TRPM2, to induce controlled hypothermia for neuroprotection in cases of stroke or cardiac arrest (PubMed Central, 2018; PNAS, 2016). Dysfunction of this center can lead to life-threatening conditions such as heatstroke or persistent hyperthermia (Britannica, 2023).

Other names

Thermoregulatory centerHypothalamic thermostatPreoptic areaPO/AHHypothalamic heat-regulating center

Antipyretic drugs act by inhibiting cyclooxygenase (COX) enzymes in the hypothalamus to reduce the synthesis of prostaglandin E2 (PGE2), thereby resetting the elevated thermoregulatory set-point back to normal. Experimental agents such as neurotensin receptor agonists act on NTR1 receptors within this center to induce a regulated decrease in core body temperature for therapeutic purposes.